Early Hepatic Dysfunction Is Associated with a Worse Outcome in Patients Presenting with Acute Respiratory Distress Syndrome: A Post-Hoc Analysis of the ACURASYS and PROSEVA Studies.

Bilirubin is well-recognized marker of hepatic dysfunction in intensive care unit (ICU) patients. Multiple organ failure often complicates acute respiratory distress syndrome (ARDS) evolution and is associated with high mortality. The effect of early hepatic dysfunction on ARDS mortality has been po...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Stéphanie Dizier, Jean-Marie Forel, Louis Ayzac, Jean-Christophe Richard, Sami Hraiech, Samuel Lehingue, Anderson Loundou, Antoine Roch, Claude Guerin, Laurent Papazian, ACURASYS study investigators, PROSEVA Study Group
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science (PLoS) 2015-01-01
Sarja:PLoS ONE
Linkit:http://europepmc.org/articles/PMC4670098?pdf=render
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia